Skip to content

Comparison of Epley Maneuver and Cinnarizine in Treatment of Benign Positional Paroxysmal Vertigo

Comparison of Epley Maneuver and Cinnarizine in Treatment of Benign Positional Paroxysmal Vertigo

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016101717413N19
Enrollment
40
Registered
2016-10-28
Start date
2015-06-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Positional Paroxysmal Vertigo. Benign paroxysmal vertigo

Interventions

Intervention 1: The first group will undergo treatment with Epley Maneuver in the first visit and two more times in first and second weeks after intervention (three times in general). Intervention 2:
Treatment - Other
Treatment - Drugs
The first group will undergo treatment with Epley Maneuver in the first visit and two more times in first and second weeks after intervention (three times in general)
The second group will undergo treatment with cinnarizine tablet (25 mg every 8 hours) for two weeks.

Sponsors

Baqiyatallah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1- Patients with definite diagnosis of BPPV 2- only up to 2 days after diagnosis 3- those who have not received any treatments for BPPV Exclusion criteria: 1- Patients with no definite diagnosis 2- those suspicious for other causes of vertigo, especially CNS involvement 3- not willing to participate 4- previous history of treatment

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Positional Paroxysmal Vertigo. Timepoint: Before, first and second week after intervention. Method of measurement: Halpike test.;Symptom Resolution. Timepoint: First and second weeks after intervention. Method of measurement: Visual Analogue Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Hossein Khosravi

Student Research Committee, Baqiyatallah University of Medical Sciences, Tehran, Iran

dr.mhkhosravi@gmail.com+98 21 8862 0826

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026